HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearchCompany Lookup
Theweek

Why is Telix buying ITM in a $1.65 billion deal?

Telix’s planned $1.65 billion acquisition of ITM is framed as a scale move in radiopharmaceuticals. The deal would combine two large pipelines and manufacturing networks, potentially giving Telix tighter control over supply, execution, and commercial readiness, with one analyst suggesting it could help the company “corner the industry.”